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Rho kinaseThe epithelial tight junction forms a barrier to paracellular solute movement. In this study we show that the
heterotrimeric G-protein Gα13 regulates the epithelial tight junction barrier. We generated MDCKII kidney
epithelial cell lines in which the expression of an active Gα13 mutant (Gα13Q226L) could be induced. We
demonstrated that Gα13Q226L expression increased paracellular permeability and caused the disruption and
redistribution of proteins comprising the tight junction and the adherens junction away from sites of cell
contact and the appearance of basal stress ﬁbers. The effects on the junctional proteins and the actin
cytoskeleton were abrogated by the Rho kinase inhibitor Y27632 but not by the Src kinase inhibitor PP2. The
Gα13 mediated increase in permeability was also Src kinase independent but was partly dependent on Rho
kinase signalling. Our data establish a link between Gα13, Rho kinase signaling and epithelial barrier
function and not only demonstrate that Gα13 regulates epithelial apical junction properties but that it does
so via signaling pathways that are distinct from the closely related protein Gα12.© 2009 Elsevier B.V. All rights reserved.1. IntroductionThe epithelial tight junction (TJ) is a continuous, circumferential,
intercellular junction located in the apical part of the lateral
membrane, which constitutes a selectively permeable barrier
between epithelial cells. The TJ is made up of multiple integral
membrane proteins, including occludin and members of the claudin
family. These form a branching network of ﬁbrils that are continuous
around the lateral membrane and form a complex with the TJ ﬁbrils of
adjacent cells to create a barrier that is largely impermeable to
macromolecules but selectively permeable to ions [1]. The integral
membrane proteins are bound to a number of tight junction-
associated cytosolic proteins, one of the best characterized being
zonula occludens 1 (ZO-1) which links the TJ to the cortical actin
cytoskeleton [2]. A variety of signaling molecules, including a number
of heterotrimeric G proteins, have been shown to localize to the tight
junction and to regulate the epithelial tight junction barrier [3–6].
Heterotrimeric G proteins consist of three subunits; α, β, and γ.
Signal transduction can be mediated by the Gα subunit, which is a
GTPase, or by the Gβγ complex. The G proteins Gαo, Gαi2, Gαs andlth Research Institute, 72 King
stralia. Tel.: +61 8 8161 7062;
owell).
ll rights reserved.Gα12 localize to the tight junction [4,7]. Gαo, Gαi2 and Gαs play roles
in tight junction assembly, while Gαi2 and Gαs are also involved in
the maintenance of tight junction barrier function [5,6,8]. In MDCKII
epithelial cells, Gα12 localizes to the peri-junctional region and to the
tight junction [4 7] where it binds ZO-1 [4]. Expression of a
constitutively active Gα12 mutant was shown to mediate disruption
of the tight junction and the adherens junction, and to increase
paracellular permeability in MDCK epithelial monolayers via a Src
dependent, Rho kinase independent pathway [9,10].
Gα13 is a member of the G12 subfamily of G proteins and has
overlapping activities with the other member of this subfamily, Gα12
[11–13]. Gα13 mediates a variety of cellular responses, including
activation of phospholipases, MAP kinases and tyrosine kinases,
cytoskeletal regulation, apoptosis and Na+/H+ exchange [11–13].
One of the best characterized downstream effects of Gα13 is the
activation of the Rho kinase signaling pathway [11–16]. The Rho
GTPase, RhoA, and its downstream effector Rho kinase play important
roles in the maintenance and modulation of the epithelial tight
junction barrier [17–23]. RhoA is thought to regulate disruption of the
tight junction by inducing contraction of the tight junction-associated
actomyosin ring via Rho kinase [21]. However, a link between Gα13,
Rho kinase andepithelial barrier functionhasnot been established. In a
microarray analysis we found that Gα13 was upregulated in epithelial
cells with impaired barrier function (Donato, R., Abbott, C. A.,
Saunders, I. and Powell, B. C., unpublished data). For this reason, as
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Gα12, a known regulator of the epithelial tight junction, we selected
Gα13 as a candidate for further functional analysis. In this study we
established stable MDCKII kidney epithelial cell lines in which
expression of a constitutively active Gα13 mutant could be induced,
andwe demonstrated that Gα13 regulates the epithelial tight junction
barrier and that it does so viamechanisms that are distinct fromGα12.
2. Materials and methods
2.1. Tetracycline inducible MDCKII Gα13Q226L cell lines
Tetracycline inducible MDCKII cell lines were generated using the
T-REx tetracycline regulated expression system (Invitrogen, Carlsbad,
CA) following the manufacturer's instructions. Parental cell lines
expressing the Tet repressor protein were generated by transfecting
MDCKII cells with the pcDNA6/TR construct using Lipofectamine
2000 (Invitrogen, Carlsbad, CA). Stably transfected clones were
selected with 6 μg/ml Blasticidin (Invitrogen, Carlsbad, CA). mRNA
levels of the tetracycline repressor in Blasticidin resistant clones were
assessed by real-time PCR (data not shown) and the highest
expressing clone was used as a parental cell line into which we
transfected the inducible expression vector (pDEST-31) containing the
Gα13Q226L cDNA. Stable, tetracycline inducible Gα13Q226L expres-
sing cell lines were selected with a combination of 6 μg/ml Blasticidin
and 400 μg/ml Geneticin (Invitrogen, Carlsbad, CA). Wild type and T-
REx tetracycline inducible MDCKII cell lines were grown in Dulbecco's
Modiﬁed Eagle's Medium (SAFC Bioscience, Lenexa, KS) containing
10% fetal bovine serum (SAFC Bioscience, Lenexa, KS), 100 μ/ml
Penicillin and 100 μg/ml Streptomycin (SAFC Bioscience, Lenexa, KS).
2.2. Permeability and inhibitor studies
Wild type and T-REx tetracycline inducible MDCKII cell lines were
seeded onto 6.5 mm diameter polycarbonate transwells with 0.4 μm
pores (Corning Life Sciences, Acton, MA) at a density of 1×106 cells/
cm2. When the transepithelial electrical resistance (TER) across the
monolayer had stabilized (after approximately 6 days), cells were
switched to media supplemented with 1 μg/ml tetracycline to induce
Gα13Q226L expression. Uninduced monolayers were given media
supplemented with vehicle alone (ethanol). In the inhibitor studies,
monolayers were pre-treated with 10 μM of the Src-inhibitor PP2
(Sigma-Aldrich, St. Louis, MO) or 10 μM of the Rho kinase inhibitor
Y27632 (Sigma-Aldrich, St. Louis,MO)orwithvehicle alone for 1 hprior
to the additionof tetracycline, andweremaintained in themediaduring
the period of tetracycline induction. Monolayer permeability was
assessed by measuring TER across conﬂuent monolayers using a
millicell-ERS volt–ohm meter (Millipore, Billerica, MA) with “chop-
stick” electrodes.Valueswere expressedasohmsper square centimeter.
Permeability was also assessed by measuring ﬂux of a 10 kDa FITC-
dextranmolecule (Sigma-Aldrich, St. Louis,MO)asdescribedpreviously
[24]. Apoptosis was assessed by measuring caspase-3/7 activity using
the APO-1 homogeneous caspase-3/7 assay (Promega, Madison, WI).
Caspase-3/7 activity levels were expressed as ﬂuorescence units. Cell
necrosis was assessed by measuring Lactate dehydrogenase (LDH)
release into the media using the Cytotox 96 Non-Radioactive Cytotoxi-
city Assay (Promega,Madison,WI). LDH levelswere expressed as a ratio
of LDH levels in themedia to total LDH(LDHactivitymeasured following
complete lysis of the cell monolayer).
2.3. Immunohistochemistry
MDCKII monolayers on transwells were washed once with ice cold
PBS and then ﬁxed by adding ice cold ethanol (100%) to the apical
chamber for 15 min at 4 °C. The ethanol was removed and 150 μl
acetone added to the apical chamber for 3 min at room temperature.Monolayers were blocked with PTB (1×PBS containing 0.1% Triton X-
100 and 5%BSA added to the apical chamber of the transwell) for
30 min at room temperature on an orbital shaker. PTB was then
removed and primary antibodies diluted in PTB were added to the
apical chamber (anti-Claudin-2, 0.5 μg/ml; anti-Occludin, 1 μg/ml;
anti-ZO-1, 1 μg/ml; anti-E-cadherin mAb 2.5 μg/ml; anti-β-catenin
mAb, 2.5 μg/ml). Antibodies for tight junction proteins were from
Invitrogen (Carlsbad, CA). Anti-E-cadherin and β-catenin antibodies
were from BD Biosciences (San Jose, CA). Monolayers were incubated
with the primary antibodies overnight at 4°C, then washed 3 times
with 0.1% Triton X-100 in PBS on an orbital shaker for 5 min at room
temperature. Monolayers were then incubated with the ﬂuorescent
conjugated secondary antibodies (Alexa ﬂuor 555 Goat anti rabbit/
mouse, 20 μg/ml; Invitrogen) for 1 h shaking at room temperature
and then washed again 3 times with Triton X-100 in PBS. Transwell
membranes were cut out with a scalpel blade and mounted on
microscope slides with Fluorescent mounting medium (Dako,
Glostrup, Denmark). Immunoﬂuorescence was visualized by confocal
microscopy using a BioRad Radiance 2100 Confocal Microscope
(Biorad, Hercules, CA) or a Nikon C1 laser scanning confocal
microscope (Nikon, Tokyo, Japan). Composite images were made
from multiple Z-sections using the public domain Java image
processing program, ImageJ (http://rsb.info.nih.gov/ij/).
2.4. Cell spreading
MDCKII Gα13Q226L (5000 cells) were plated sub-conﬂuently on
transwells and induced with tetracycline for 6 h in the presence or
absence of Src kinase PP2 inhibitor (10 μM). Cells were washed twice
in TBS (0.15 M NaCl, 0.02 M Tris–Cl, pH 7.4) and then ﬁxed in 4%
formaldehyde in CBS (10 mM MES pH 6.1, 138 mM KCl, 3 mM MgCl2,
2 mM EGTA) in the apical chamber for 20 min. Cells were then rinsed
in TBS and permeabilized in TBS–0.5% Triton X for 10 min and washed
three times in TBS–0.1% Triton X for 3min. Cells were blocked in 150 μl
Abdil solution (TBS–0.1% Triton X, 2% BSA, 0.1% sodium azide) for
10 min and subsequently incubated with Alexa ﬂuor 488 phalloidin
(Invitrogen, Carlsbad, CA) diluted in Abdil solution (1:80) for 20 min.
Cells were washed twice in TBS–0.1% Triton X and rinsed in TBS.
Transwell membranes were cut out and mounted on microscopic
slides with ﬂuorescentmountingmedium (Dako, Glostrup, Denmark).
The surface area of single, isolated cells was measured under phase
contrast using Analysis Software (Soft Imaging Systems, GmbH).
Immunoﬂuorescence was visualized using a Leica DMRB microscope
(Leica, Germany). The brightness of the phase contrast images was
adjusted in Adobe Photoshop for presentation. Note: the speckles in
the phase contrast images are the pores in the transwell membrane.
2.5. Statistical analysis
Experiments were performed in triplicate. Results are expressed as
mean+/−standard deviation. Statistical analysis was performed
using SPSS for Windows (SPSS Inc., Chicago, IL). One-way ANOVA
with the Tukey HSD post-hoc test were used to compare results, with
statistical signiﬁcance assumed to be at pb0.05. For the comparison of
cell spreading, statistical analysis was performed using GraphPad
Prism 5 forWindows. A pairwise Student's t-test was used to compare
data, with statistical signiﬁcance assumed to be at Pb0.05.
3. Results
3.1. Expression of a constitutively active Gα13 mutant of Gα13Q226L in
MDCK monolayers results in increased paracellular permeability and
disruption of junctional proteins
In order to assess the effect of increased Gα13 activity on epithelial
apical junctions and barrier function, tetracycline inducible MDCKII
Fig. 1. Gα13 induction increases paracellular permeability in MDCKII cells. (A) Western
blot of Gα13 protein levels after 6 h induction of the constitutively active Gα13 mutant,
Gα13Q226L, with 1 μg/ml tetracycline in three stable MDCKII clonal cell lines. (B)
Transepithelial electrical resistance (TER) of wild type and Gα13Q226L monolayers
with/without (+/−) tetracycline after 2, 4 and 6 h induction. (C) 10 kDa FITC-dextran
ﬂux across MDCKII wild type and MDCKII Gα13Q226L monolayers following 6 h
tetracycline induction. (D) Apoptosis in Gα13Q226L MDCKII monolayers as measured
by Caspase-3/7 activity. (E) Lactate dehydrogenase (LDH) release in Gα13Q226L
monolayers following 6 h tetracycline induction. N=3 for B–E. ⁎Signiﬁcantly different
to uninduced monolayer of the same cell line at the same time point (Pb0.05).
Fig. 2. Gα13 induction disrupts the membrane localization of tight junction and
adherens junction proteins and of F-actin. MDCKII Gα13Q226L monolayers were
treated with/without (+/−) tetracycline for 6 h. Monolayers were subsequently
immunostained for Claudin 2 (A), ZO-1 (B), Occludin (C), E-cadherin (D), β-catenin (E)
and F-actin (F, G). Representative images are shown and are composites of multiple
confocal Z-sections. Bar, for all panels, 5 μm.
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mutant, Gα13Q226L. An inducible expression system was used to
avoid any adverse effects that constitutive expression might have hadon cell differentiation and tight junction formation. We generated
three independent, tetracycline inducible cell lines which all had
increased levels of expression following 6 h of induction (Fig. 1A). The
1231R. Donato et al. / Biochimica et Biophysica Acta 1793 (2009) 1228–1235data presented in this study were replicated using at least two of these
cell lines.
To measure the effect of Gα13Q226L expression on tight junction
barrier function, the permeability of monolayers was assessed by
measuring transepithelial electrical resistance (TER) and transepithe-
lialmacromolecular ﬂux,where a decrease inTER indicates an increase
in permeability to ions and an increase in macromolecular ﬂux
indicates an increase in permeability to large uncharged molecules.
The baseline permeability of monolayers of the Gα13Q226L cell lines
was similar to that of wild type (untransfected) MDCKII cells (Fig. 1B
and C). A decrease inTERwas evident as early as 2 h post induction and
approached 50% reduction by6h (Fig.1B). A several fold increase in the
ﬂux of 10 kDa FITC-dextran molecules across the monolayer was
measured after 6 h induction (Fig.1C). Because increased permeability
of epithelial monolayers can also result from an increase in cell death,
we assessed the level of apoptosis and necrosis. Induction of
Gα13Q226L expression did not cause an increase in caspase-3/7
activity (Fig. 1D) or an increase in lactate dehydrogenase release into
the media (Fig. 1E) accepted biological measures of apoptosis and
necrosis, respectively, indicating that the increase in monolayer
permeability was not due to apoptosis or necrosis.
Changes in epithelial monolayer permeability are often associated
with alterations in junctional proteins. Hence,wenext investigated the
effect of Gα13Q226L on proteins representative of the tight junction
and the adherens junction. In contrast to the uniform appearance of
junctional proteins of uninduced monolayers, Gα13Q226L induction
resulted in an irregular and disrupted appearance at the lateral
membranes of the tight junction proteins claudin 2, ZO-1 and occludin
and the adherens junctionproteins, E-cadherin andβ-catenin (Fig. 2A–
E). Staining of actinwith FITC-Phalloidin also revealed a reorganization
of the cortical actin cytoskeleton and the appearance of basal stress
ﬁbers (Fig. 2F, G). These data indicate that expression of Gα13Q226L in
MDCKII monolayers results in an increase in paracellular permeability
that is associated with changes in proteins at the apical junctions.
3.2. Gα13 increases MDCK tight junction disruption and permeability via
a Src tyrosine kinase independent pathway
The increase in permeability and disruption of the apical junctions
in MDCKII monolayers overexpressing Gα12 is abrogated by the SrcFig. 3. Gα13 induction increasesMDCKII monolayer permeability via a Src tyrosine kinase ind
tetracycline and with/without (+/−) the Src kinase inhibitor PP2 (10 μM) for 6 h, and the
measured as previously described.N=3 for all experiments. ⁎ indicates a signiﬁcant differenc
difference compared to uninduced monolayer without inhibitor, to tetracycline induced montyrosine kinase inhibitor PP2 [9]. When we treated Gα13Q226L
expressing monolayers with PP2, neither the decrease in TER (Fig. 3A)
nor the increase in macromolecular ﬂux were abrogated (Fig. 3B).
Instead, PP2 exacerbated both permeability parameters, further
decreasing TER and increasing FITC-dextran ﬂux several fold. This
effect was speciﬁc tomonolayers inwhich Gα13Q226L expressionwas
induced (Fig. 3A, B). PP2 had no effect on caspase activity (Fig. 3C) or
LDH release (Fig. 3D). In monolayers expressing Gα13Q226L, PP2 did
not prevent the redistribution of the tight junction protein occludin
(Fig. 4A), or of the adherens junction proteins E-cadherin (Fig. 4B) and
β-catenin (Fig. 4C) away from the lateral membrane, or the
remodeling of the actin cytoskeleton (Fig. 4D). However, neither did
any of these changes appear noticeably enhanced by PP2. These data
suggest that Gα13 regulates epithelial apical junction disruption and
increased paracellular permeability via a Src independent pathway,
unlike Gα12 [9].
A possible reason for the enhanced permeability of Gα13Q226L
expressing monolayers treated with PP2 compared to those without
treatment was suggested by analysis of monolayers stained for F-actin
and cell nuclei. Whereas monolayers expressing Gα13Q226L in the
absence of PP2 or uninduced monolayers exposed to PP2 alone,
appeared normal (Fig. 5A, B), Gα13Q226L expressing monolayers
exposed to PP2 contained scattered holes about the size of single cell
at a frequency of 1 in 23 cells (Fig. 5C). The appearance of the cells
surrounding the holes was not noticeably different from those in
Gα13Q226L expressing monolayers not treated with the inhibitor.
Because the frequency of the holes was consistent with the incidence
of normal apoptotic events in epithelial monolayers [25] we tested for
any effects on cell spreading. Fig. 6 shows that Gα13Q226L induction
in the presence of PP2 caused a striking reduction in the spreading of
the cells.
3.3. Gα13 regulates MDCK apical junctions and permeability through a
Rho kinase dependent pathway
As our data suggested that Gα13 regulates apical junctions and
epithelial permeability via a Src independent pathway, we
attempted to determine what this pathway might be. Rho is a
known regulator of tight junction structure and barrier function
[18,21] and a well characterized effector of Gα13 [13,26,27]. Rho isependent pathway.MDCKII Gα13Q226Lmonolayers were treatedwith/without (+/−)
effect on TER (A), FITC-dextran ﬂux (B), caspase activity (C) and LDH release (D) was
e compared to uninducedmonolayerwithout inhibitor (Pb0.05). † indicates a signiﬁcant
olayer without inhibitor and to uninduced monolayer with inhibitor (pb0.05).
Fig. 4. The Src kinase inhibitor, PP2, does not prevent the effect of Gα13 induction on the localization of tight junction or adherens junction proteins, or of F-actin. MDCKII Gα13Q226L
monolayers were treated with/without (+/−) tetracycline and with/without (+/−) the Src kinase inhibitor PP2 (10 μM) for 6 h. Monolayers were subsequently immunostained
for Occludin (A), E-cadherin (B), β-catenin (C) or F-actin (D). Representative images are shown and are composites of multiple confocal Z-sections. Bar, for all panels, 5 μm.
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kinase, which mediates increased phosphorylation of myosin and
contraction of the tight junction-associated actomyosin ring [21,22].
Indeed, the remodeling of the cortical actin cytoskeleton and the
appearance of basal stress ﬁbers in Gα13Q226L expressing mono-
layers (Fig. 2F, G) is consistent with the involvement of the Rho
kinase pathway in these cells. To determine whether the Rho kinase
pathway mediates Gα13 regulation of the MDCK apical junctions
and permeability we tested the effect of the Rho kinase inhibitor
Y27632. When Y27632 was given prior to induction of Gα13Q226L
it attenuated the drop in TER caused by Gα13Q226L by about half
(Fig. 7A) but did not prevent the increase in macromolecular ﬂux
(Fig. 7B). There was no change in caspase activity (Fig. 7C)
indicating that there was no change in apoptosis, nor in necrosisFig. 5. Gα13 induction in the presence of Src kinase inhibitor affects monolayer integrity. Es
Src kinase inhibitor PP2 for 6 h. Monolayers were stained with FITC-phalloidin to visualize
Gα13Q226Lmonolayers. (B) Gα13Q226Lmonolayers+PP2 inhibitor. (C) Gα13Q226Lmono
counted and 200 holes recorded. Scale bar, 15 μm.as measured by the LDH assay (Fig. 7D). However, Y27632
treatment clearly prevented the Gα13 induced disruption of
occludin (Fig. 8A), E-cadherin (Fig. 8B) and β-catenin (Fig. 8C). It
also prevented the Gα13 induced reorganization of the actin
cytoskeleton (Fig. 8D).
4. Discussion
In this study we focused on the regulation of the epithelial apical
junctions and barrier function by Gα13. Like the closely related
protein Gα12 [9], expression of a constitutively active Gα13 mutant in
MDCKII monolayers resulted in a disrupted distribution of tight
junction and adherens junction proteins at the lateral membrane,
reorganization of the actin cytoskeleton and an increase intablished MDCKII Gα13Q226L monolayers were treated +/−tetracycline and +/−the
the actin cytoskeleton (green) and with DAPI (blue) to visualize nuclei. (A) Untreated
layers+tetracycline+PP2 inhibitor. Holes are indicated by arrowheads. 4500 cells were
Fig. 6.Gα13 induction in thepresenceof Src kinase inhibitor affects cell spreading.MDCKII
Gα13Q226L cellswere plated sub-conﬂuently on transwells and inducedwith tetracycline
for 6 h in the presence or absence of Src kinase PP2 inhibitor (10 μM). A, C, phase contrast;
B, D, actin staining. (A, B)Gα13Q226L cells treatedwith tetracycline and PP2. A cell cluster
appears at the topof the image. (C, D)Gα13Q226L cells treatedwith tetracycline alone. (E)
Surface area of single, isolated Gα13Q226L expressing cells.N=26 for+tetracycline only
cells andN=31 for+tetracycline+PP2 cells.⁎ indicates a signiﬁcant difference compared
to cells without PP2 (Pb0.0001). Scale bar for all panels, 15 μm.
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apical junctions and the paracellular barrier has previously been
shown to be abrogated by the Src kinase inhibitor PP2 [9]. However, inFig. 7. Gα13 regulates epithelial monolayer permeability in part via the Rho kinase pathway.
and with/without the Rho kinase inhibitor, Y27632 (10 μM) and the effect on TER (A), FITC-
described. N=3 for all experiments. ⁎ indicates a signiﬁcant difference compared to uninduc
to uninduced monolayer without inhibitor, to tetracycline induced monolayer without inhiour study with MDCKII cell lines expressing a constitutively active
Gα13 mutant, treatment with the same concentration of PP2 did not
prevent the increase in permeability or disruption of the apical
junction proteins. Surprisingly, treatment with this inhibitor had the
opposite effect, potentiating the Gα13-mediated increase in perme-
ability. These data suggest that Gα13 regulates disruption of the
epithelial apical junctions and paracellular barrier by different
signaling pathways to those activated by Gα12.
Gα13 is known to activate the small GTPase Rho [13,26,27]
whose overexpression disrupts epithelial tight junctions and
adherens junctions and the paracellular barrier in MDCKII cells
[18,21]. When we investigated the role of the Rho effector, Rho
kinase, we found that inhibition by Y27632 appeared to prevent the
Gα13-induced redistribution of apical junction proteins and the
reorganization of the cortical actin cytoskeleton. These data suggest
that Gα13 regulates disruption of the organization of the apical
junction proteins at the membrane through a Rho kinase dependent
pathway, perhaps via reorganization of the apical junction-asso-
ciated actomyosin ring. However, the mechanism by which Gα13
induction affects permeability is more complex. The decrease in TER
induced by Gα13 was attenuated by about 50% by the Rho kinase
inhibitor but the increase in macromolecular ﬂux was not affected,
suggesting that ﬂux was mediated by a Rho kinase independent
pathway. This differential effect of Y27632 on TER and macro-
molecular ﬂux could be explained by the fact that they measure
different parameters. Whereas TER is an instantaneous measure-
ment of permeability to ions, ﬂux measures permeability to
macromolecules over a period of hours [21,28]. Furthermore, a
number of studies have shown epithelial paracellular ion and solute
ﬂux to be independently regulated [3]. It is also possible that the
increase in macromolecular ﬂux was due to an increase in the rate
of transcytosis, also independent of Rho kinase, rather than an
increase in paracellular permeability to macromolecules.
Constitutively active Gα13 and Gα12 have been shown to bind
directly to E-cadherin in vitro and to block cadherin-mediated cell
adhesion, resulting in release of β-catenin from the cadherin complex
[29,30]. For Gα12, these events appeared to be Rho kinase
independent, as was the effect of Gα12 on MDCK barrier function.
Our data show that the Gα13 induced disruption of adherens junction
proteins inMDCK epithelial monolayers wasmediated by a Rho kinaseMDCK II Gα13Q226L monolayers were treated for 6 h with/without (+/−) tetracycline
dextran ﬂux (B), caspase activity (C) and LDH release (D) was measured as previously
ed monolayer without inhibitor (Pb0.05). † indicates a signiﬁcant difference compared
bitor and to uninduced monolayer with inhibitor (pb0.05).
Fig. 8. Gα13 induction regulates localizationof tight junctionandadherens junctionproteins andF-actinvia theRhokinasepathway.MDCKIIGα13Q226Lmonolayerswere treatedwith/
without (+/−) tetracycline andwith/without (+/−) the Rho kinase inhibitor Y27632 (10 μM) for 6 h. Monolayers were subsequently immunostainedwith Occludin (A), E-Cadherin
(B), β-catenin (C) or F-actin (D). Representative images are shown and are composites of multiple confocal Z-sections covering the apical junction region. Bar, for all panels, 5 μm.
1234 R. Donato et al. / Biochimica et Biophysica Acta 1793 (2009) 1228–1235dependent mechanism. Taken together with studies of Gα12 over-
expression [9] our data indicate that Gα12 and Gα13 regulate
epithelial apical junction proteins and the paracellular barrier through
distinct pathways. Whereas Gα12 signals through a Src kinase
dependent, Rho kinase independent pathway [9] Gα13 signaling
appears to be more complex. Gα13 regulates junctional protein
localization via Src kinase independent and Rho kinase dependent
pathways but regulates permeability by pathways independent of Src
kinase but partly dependent on Rho kinase. This extends the spectrum
of cellular functions that are known to be regulated differentially by
Gα12 and Gα13, including Na+/H+ exchange [31], stress ﬁber
formation [32], the Jun Kinase/stress-activated protein kinase path-
way [33], non-receptor tyrosine kinases and A-kinase anchoring
proteins [11,12]. The reason why Gα12 and Gα13 regulate apical
junction disruption via different signaling pathways may be explained
by the ﬁnding by Meyer et al. [4] who showed that ZO-1 acts as a
scaffold to anchor Gα12, but not Gα13, to the tight junction. This may
allow Gα13 to engage different effectors.
The inhibition of Src kinase activity in Gα13Q226L expressing
monolayers with PP2 produced an unexpected result in that the
inhibitor resulted in a greater increase in paracellular permeability.
This coincided with the appearance of scattered holes, about the
size of a single cell, in an otherwise normal monolayer. Their
appearance was not associated with an increase in apoptosis or
necrosis. A possible explanation is that they resulted from impaired
restitution of single cell defects that occur from random apoptotic
events in cell monolayers, and their frequency was consistent with
the population of cells (3%) that naturally undergo apoptosis in
epithelial cell monolayers [25]. Under normal circumstances inmonolayers, spreading by cells adjacent to the apoptosing cell acts
to maintain cell contact and integrity of the barrier [34]. Cell
spreading requires a localized and transient Src kinase dependent
downregulation of RhoA activity to facilitate a reduction in focal
adhesions and stress ﬁbers that would otherwise inhibit spreading
[35–40]. As Gα13 induces stress ﬁbers in a Rho kinase dependent
manner (e.g., Fig. 8D) [41] we speculate that induction of Gα13
leads to an increase in RhoA activity and, that when Src is inhibited,
the localized and transient downregulation of RhoA that is required
to enable the cell spreading cannot occur. This leads to an inability
of the monolayer to maintain barrier function in response to normal
apoptotic cell loss. Our ﬁnding that Gα13 induction in the presence
of the PP2 Src kinase inhibitor dramatically reduces cell spreading is
consistent with this hypothesis.
In conclusion, our study establishes that activated Gα13 mediates
disruption of proteins at the tight junction and the adherens junction
and regulates epithelial cell permeability, partly by engaging Rho
kinase pathways, and it provides further insight into the subtleties of
signaling by the Gα family by showing that Gα13 acts on apical
junctional proteins and cell permeability via signaling pathways that
are different to those engaged by Gα12.
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